Compare · head to head
Granules India vs Laurus Labs
Granules India ranks higher overall — 360 rank 65 vs 28.
Granules India leads on Value (34 vs 13), Quality (58 vs 48) and Safety (66 vs 42). Laurus Labs leads on Growth (73 vs 64) and Sentiment (49 vs 44).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | India | India |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Medium | Large |
| ISIN | INE101D01020 | INE947Q01028 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 65 | 28 |
| Value | 34 | 13 |
| Quality | 58 | 48 |
| Growth | 64 | 73 |
| Safety | 66 | 42 |
| Sentiment | 44 | 49 |
| Quality details | ||
| Profitability | 73 | 50 |
| Cash Truth | 43 | 45 |
Granules India vs CiplaGranules India vs Dr. Reddy'sGranules India vs ZydusGranules India vs Vinati OrganicsAdd a third stock →
Full analyses: Granules India · Laurus Labs
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100